<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=2713&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="365846" class="table-">
                
                <td>March 20, 2022, 9:56 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;Formulation 1&quot;, &quot;treatment_id&quot;: 1154, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;Formulation 2&quot;, &quot;treatment_id&quot;: 1154, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;Formulation 3&quot;, &quot;treatment_id&quot;: 1154, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1935, &quot;treatment_name&quot;: &quot;As03 adjuvant+sars-cov-2 recombinant protein vaccine monovalent (b.1.351)&quot;, &quot;treatment_type&quot;: &quot;Adjuvant+protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;Dosage 1&quot;, &quot;treatment_id&quot;: 1936, &quot;treatment_name&quot;: &quot;As03 adjuvant+sars-cov-2 recombinant protein vaccine monovalent (d614)&quot;, &quot;treatment_type&quot;: &quot;Adjuvant+protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;Dosage 2&quot;, &quot;treatment_id&quot;: 1936, &quot;treatment_name&quot;: &quot;As03 adjuvant+sars-cov-2 recombinant protein vaccine monovalent (d614)&quot;, &quot;treatment_type&quot;: &quot;Adjuvant+protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: 1934, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine bivalent (d614+b.1.351)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;previously unvaccinated, na\u00efve participants&quot;, &quot;treatment_id&quot;: 1932, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine monovalent (d614)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;prior with an authorized mRNA COVID-19&quot;, &quot;treatment_id&quot;: 1933, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;prior with an authorized mRNA COVID-19&quot;, &quot;treatment_id&quot;: 1933, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;prior with an authorized mRNA COVID-19&quot;, &quot;treatment_id&quot;: 1933, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;prior with an authorized mRNA COVID-19&quot;, &quot;treatment_id&quot;: 1933, &quot;treatment_name&quot;: &quot;Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)&quot;, &quot;treatment_type&quot;: &quot;Protein subunit&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="181452" class="table-">
                
                <td>Jan. 29, 2022, 11:30 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="131021" class="table-">
                
                <td>July 24, 2021, 11 p.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="90281" class="table-">
                
                <td>Feb. 23, 2021, 12:31 a.m.</td>
                <td>usa</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Formulation 1&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Formulation 2&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}, {&quot;arm_notes&quot;: &quot;nan&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;SARS-CoV-2 recombinant protein vaccine Formulation 3&quot;, &quot;treatment_type&quot;: &quot;Biological&quot;, &quot;pharmacological_treatment&quot;: &quot;Non pharmacological treatment&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
March 20, 2022, 9:56 a.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]	[{"arm_notes": "Formulation 1", "treatment_id": 1154, "treatment_name": "Sars-cov-2 recombinant protein vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Formulation 2", "treatment_id": 1154, "treatment_name": "Sars-cov-2 recombinant protein vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Formulation 3", "treatment_id": 1154, "treatment_name": "Sars-cov-2 recombinant protein vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "nan", "treatment_id": 1935, "treatment_name": "As03 adjuvant+sars-cov-2 recombinant protein vaccine monovalent (b.1.351)", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Dosage 1", "treatment_id": 1936, "treatment_name": "As03 adjuvant+sars-cov-2 recombinant protein vaccine monovalent (d614)", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Dosage 2", "treatment_id": 1936, "treatment_name": "As03 adjuvant+sars-cov-2 recombinant protein vaccine monovalent (d614)", "treatment_type": "Adjuvant+protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "nan", "treatment_id": 1934, "treatment_name": "Sars-cov-2 recombinant protein vaccine bivalent (d614+b.1.351)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "previously unvaccinated, na\u00efve participants", "treatment_id": 1932, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (d614)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "prior with an authorized mRNA COVID-19", "treatment_id": 1933, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "prior with an authorized mRNA COVID-19", "treatment_id": 1933, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "prior with an authorized mRNA COVID-19", "treatment_id": 1933, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "prior with an authorized mRNA COVID-19", "treatment_id": 1933, "treatment_name": "Sars-cov-2 recombinant protein vaccine monovalent (b.1.351)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]
Jan. 29, 2022, 11:30 a.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]
July 24, 2021, 11 p.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, bivalent (D614+B.1.351)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03 Alternative Exploratory Formulation 4", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (B.1.351)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage A", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 adjuvanted recombinant protein vaccine, monovalent (D614)-AS03, Dosage B", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Phase 2 Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]
Feb. 23, 2021, 12:31 a.m.	usa	[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Formulation 1", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Formulation 2", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "SARS-CoV-2 recombinant protein vaccine Formulation 3", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]